MGX
Metagenomi, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$1.17
+0.86%Margins
Gross margin
74.3%
EBITDA margin
-652.5%
EBIT margin
-741.6%
Net margin
-689.2%
FCF margin
-632.7%
-83.0%
Return on equity
-53.8%
Return on assets
-66.9%
Return on invested capital
0.07x
Asset turnover
-$85.5M
Cash from operations
$3.19
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026